期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 67, 期 6, 页码 -出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/aac.00374-23
关键词
fluoroquinolone; hypersensitivity; allergy; cross-reactivity
Results from a large multicenter study suggest that patients with confirmed hypersensitivity reactions to ciprofloxacin, moxifloxacin, or levofloxacin are likely to tolerate other fluoroquinolones. Avoiding different fluoroquinolones in patients with labeled allergies to ciprofloxacin, moxifloxacin, or levofloxacin may not always be necessary.
Results from this large, multicenter study suggest that patients with a confirmed ciprofloxacin, moxifloxacin, or levofloxacin hypersensitivity reaction are likely to tolerate other fluoroquinolones. Avoiding different fluoroquinolones in patients labeled with a ciprofloxacin, moxifloxacin, or levofloxacin allergy may not always be mandatory. This was a study of patients with a ciprofloxacin, moxifloxacin, or levofloxacin hypersensitivity reaction and a documented electronic medical record administration of a different fluoroquinolone. Numerically, the most common reaction risk occurred with a challenge to moxifloxacin (2/19; 9.5%), followed by ciprofloxacin (6/89; 6.3%), and levofloxacin (1/44; 2.2%). Results from this large, multicenter study suggest that patients with a confirmed ciprofloxacin, moxifloxacin, or levofloxacin hypersensitivity reaction are likely to tolerate other fluoroquinolones. Avoiding different fluoroquinolones in patients labeled with a ciprofloxacin, moxifloxacin, or levofloxacin allergy may not always be mandatory.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据